Wednesday, July 12, 2006

Negative feedback from Healthcare Services

A good friend of the family just had a heart attack not too long ago and he shared his experiences at the hospital that I found a bit discerning.

"I was resting in the emergency room, after almost all of my test results and x-rays came back negative, the emergency room physician was telling me that it was quite normal to over react after having experienced one heart attack and was apparently getting ready to pronounce me fit, the nurse came in with the results of my latest round of blood tests showing that I had indeed experienced a heart attack. The physician got up and left. The nurse said that he would come back and brief me on my condition. He didn't. They kept me overnight before transferring me to Inova Fairfax for an angioplasty. The nurse explained everything to me but again said that the doctor would brief me the following morning before being transferred on what was going to happen. I wasn't transferred until late that afternoon, but the doctor never showed. He may have been embarrassed but I wasn't upset. I thought it was laughable. Nobody's perfect.
There was one thing that did piss me off, though. The nurse that admitted me was friendly and courteous. After asking me a lot of questions, she went over to a terminal and started entering information and scheduling tests. A black nurse came in and sat near and started asking questions about me. I couldn't hear them clearly but they were not facing me but kept turning and looking at me. At one point the white nurse shook her head and said loud enough for me to hear her clearly, "He doesn't have any insurance." The black nurse questioned this and the white nurse stood up and asked loudly, "Do you have any insurance?' I responded with the names of my insurances. Instead of asking me when she was asking me all of the other questions or when it first occurred to her, she made assumptions based presumably on my race and age that determined what tests and other care I was to receive. I'm still ticked off about that. I don't think that she necessarily disliked black people. It's just that racial and other stereotypes are a common part of people's decision process."

This is the reason that we stray away from Healthcare because we are judged and the feedback that we want to receive is negative. This is what further draws us to the internet because we get the answers that we have questions to, we get the support groups and we are not discriminated because the only thing that the other person can see is their own screen and not the color of our skin. Positive feedback from the internet and self-reliance to care for our own health is where we have evolved.

Metrosexual OR Not?

There was a discussion that I had at work today about this one co-worker's shoe. This is not by any means educational or work related but I'm very curious as to what you think about these shoes for men. His claim is that only men who know style can wear and appreciate these shoes but many of the females at work thought they were very feminine and could see themselves wearing it but not for their significant others such as boyfriends or husbands.

What do you think of these Nike Air Rift for Men?
Metrosexual shoes and cool for a man to wear.
Nice for a guy, but I wouldn't wear it.
Perfect for a woman but not for a man.
Free polls from

Tuesday, July 11, 2006

Clinical Trials available for all those with Chronic Hepatitis B

There are continually open clinical trials for people with chronic Hepatitis B. This is a call out to those with Chronic Hepatitis B to contribute to the better well-being of science and to the future generation that may not have to suffer. These different clinical trials have a number of antiviral drug trials,new non-invasive devices, effectiveness of new treatment, liver transplant study, controlling resistant strands and more. Updates of current Hepatitis B clinical trials.

This method of recruiting, as discussed in the benefits of the internet is a way that health professions actively promote new trials and are able to establish a large sample size. This allows people with chronic Hepatitis to have control over their disease and also give back to others. This clinical databank is enhancing the new waves of media to reach out to people.

Monday, July 10, 2006

Stigma and Hepatitis B

The transmission of Hepatitis B is very similar to HIV/AIDS and the high risk groups are also equally similar. The high risk groups include men who have sex with men (MSM), injection drug users and health care workers. The virus can spread both parenterally and through sexual activity. This may be a reason why there is stigmatization associated with viral Hepatitis.

Do you believe there is stigmitization associated with Hepatitis B patients?
Yes, I believe they are
Yes, I know so from personal experience
No, I don't see a stigma attached to the disease
No, I've never encountered negative reactions aimed at me
Free polls from

Man Missing Skull

Baconboy brought me to the attention of a man missing his skull. . Sambhu Roy's was an electrician who was severely burned after being electrocuted from a high voltage wire. The infected area on his skull lacked blood supply and his skull was beginning to loosen. The skull came off and another covering was formed. The article is found in “Piece of man's skull falls off, draws crowds

He is definitely a man with many lives. He not only survives being electrocuted but the membrane under his skull was not affected. His body pushed the damaged skull out and formed a new skin. In my opinion, this is unbelievably astonishing and a miracle that he is still alive.

Friday, July 07, 2006

GREAT NEWS for people with Chronic Hepatitis B

On June 28, Bristol-Myers Squibb announced that the European Commission approved entecavir (Baraclude) for the treatment of chronic hepatitis B virus (HBV) infection.

Entecavir was approved by the U.S. Food and Drug Administration in June 2005. The other agents approved for hepatitis B treatment are lamivudine (3TC, Epivir-HBV), adefovir dipivoxil (Hepsera), and conventional and pegylated interferon alfa.

Entecavir is an oral antiviral agent that blocks HBV replication of detectable HBV DNA. Studies have shown that entecavir supresses HBV replication in patients with both HBeAg-positive and HBeAg-negative hepatitis B, and protects against the HBV that is lamivudine-resistant.

This approval means that other countries will benefit from this drug as well. This will reduce the worldwide disparity of people suffering with chronic hepatitis B and drop it from being the tenth leading cause of death. There is no reason why people should die from Hepatitis B. There is a cure and also prevention mechanisms from vaccination to eliminate spread.

Thursday, July 06, 2006

Bandwagon amatuer!

All this new talk about wonder drugs makes me wonder if I should jump on some pharmaceutical bandwagon and put some money into investing in these companies (i.e. Merck, GlaxoSmithKline, Bristol Myers, Pzifer). The new HIV/AIDS pill, Entecavir for Hepatitis B and a new smoking cessation drug from Pzifer. I may be too late; the band wagon may have completely passed me by. But if anyone hears anything new, please tell me before the stocks to these companies sky rocket again. But as for now, I'm keeping my ears and eyes open before something new and big happens.

Drug for Resistant Lamividine Drug Therapy against HBV

The greatest challenge faced against treatment of Hepatitis B virus (HBV) was the resistance to lamividine drug therapy. In a prospective, randomized, controlled trial, patients with lamivudine resistance HBeAg-positive chronic HBV infection were randomly assigned to either receive the entecavir (Baraclude) or remain on lamivudine for at least 48 weeks.

All the patients were analyzed by their HBV DNA copies and by a Knodell fibrosis score. The relationship between efficacy and baseline disease and demographic characteristics was assessed.
After 48 weeks, patients who received entecavir experienced HBV DNA reduction of 5.11 log10 copies/mL, compared with a reduction of 0.48 log10 copies/mL among patients receiving lamivudine. Patients that were taking entecavir experience histological improvement compared to those taking lamivudine (55% vs 28% respectively).

This is another great wonder drug and specific for Hepatitis B. This will help the strain that is resistant to lumivudine hepatitis B drug therapy and reduce the chronic conditions of Hepatitis B to almost non-existence. I wish this drug was around when my dad was suffering from HBV so that he might be able to get through his illness and be alive today. The more I learn about this disease, the more I wonder about my dad’s prognosis. I was too young to understand or even know about the disease itself. More questions when I found a few answers.

Wednesday, July 05, 2006

Three in One! Wonder Drug

There is a new antiviral medicine that combines the three most common first line drugs against HIV/AIDS that are known as zidovudine, lamivudine and nevirapine. This is a great advantage for people that suffer from HIV/AIDS because it allows better adherence and makes the chances of living longer a little less complicated. Another great aspect of these drugs is that it is generically made and therefore allows it to be better priced for the poor, specifically poor countries such as Africa. This is a great new wonder pill. The things that scientist are coming up with are amazing, but it makes me wonder if we find a cure for AIDS then what may be the next big disease. To read more about this pill, Click on "Cheap AIDS pill as good as pricey brands"

Tuesday, July 04, 2006

Fourth Of July Tribute

Happy Fourth of July! I hope that I'm not the only one stuck indoors working on my Lit. Review.